KATHLEEN LAWSON: Open Payments
NPI 1174396121 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 13 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $39 · 2025 $394
Food & beverage: $309Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $187 |
| Ardelyx, Inc. | 2 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $51 |
| ABBVIE INC. | 2 | $48 |
| Lilly USA, LLC | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
Products named: TREMFYA, IBSRELA, XIFAXAN, OMVOH, ENTYVIO, RINVOQ, CREON.
Industry payments across DC — which companies pay providers there.
